XML 49 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended 389 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Cash flows from operating activities:        
Net loss $ (121,287) $ (2,318) $ (32,177) $ (431,251)
Adjustments to reconcile net loss to net cash flows used in operating activities:        
Depreciation and amortization 1,525 1,300 1,463 21,970
Loss on disposal of assets 357 190 776 2,636
Realized gain on sale of short-term securities-available-for-sale 0 0 0 (3,863)
Write-down of short-term securities-available-for-sale 0 0 0 17,001
Impairment charge on real estate owned 0 109 408 1,445
Stock-based compensation 3,078 3,129 3,169 32,073
Acquired in-process research and development 0 0 0 29,461
Increase (decrease) on warrant valuation 91,938 (33,022) 11,502 66,968
Net increase in accounts receivable and other assets (3,587) (1,063) (1,211) (8,761)
Net increase (decrease) in accounts payable, accrued employee compensation, and other liabilities (1,718) 7,996 861 12,413
Net cash used in operating activities (29,694) (23,679) (15,209) (259,908)
Cash flows from investing activities:        
Purchase of property and equipment (108) (1,178) (832) (19,987)
Patent costs (1,037) (1,127) (1,122) (10,529)
Purchase of marketable securities 0 0 (7) (112,993)
Sale of marketable securities 0 0 0 117,724
Acquisition costs 0 0 0 (2,389)
Net cash used in investing activities (1,145) (2,305) (1,961) (28,174)
Cash flows from financing activities:        
Proceeds from sale of common stock, warrants, and partnership units, net of offering costs, and exercise of options and warrants 178,681 32,380 2,561 476,559
Repayments of long-term debt (85) (81) (77) (430)
Other financing activities, net 0 0 0 (386)
Net cash provided by financing activities 178,596 32,299 2,484 475,743
Increase (decrease) in cash and cash equivalents 147,757 6,315 (14,686) 187,661
Cash and cash equivalents:        
Beginning of period 39,904 33,589 48,275 0
End of period 187,661 39,904 33,589 187,661
Supplemental Disclosure of Cash Flow Information:        
Cash paid during the year for interest 86 90 94 575
Supplemental Schedule of Noncash Investing Activities and Financing Activities:        
Short-term securities-available-for-sale received in connection with the private offering 0 0 0 17,897
Issuance of common stock in satisfaction of warrants and other liabilities 32,191 643 0 32,834
Issuance of common stock for building purchase 0 0 0 750
Assumption of long-term debt for building purchase 0 0 0 2,200
Issuance of common stock to acquire assets 0 0 0 8,075
Assumption of liabilities to acquire assets $ 0 $ 0 $ 0 $ 2,124